Growth Metrics

Jazz Pharmaceuticals (JAZZ) Goodwill & Intangibles (2016 - 2025)

Historic Goodwill & Intangibles for Jazz Pharmaceuticals (JAZZ) over the last 17 years, with Q3 2025 value amounting to $6.4 billion.

  • Jazz Pharmaceuticals' Goodwill & Intangibles fell 799.62% to $6.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 billion, marking a year-over-year decrease of 799.62%. This contributed to the annual value of $6.5 billion for FY2024, which is 974.95% down from last year.
  • Per Jazz Pharmaceuticals' latest filing, its Goodwill & Intangibles stood at $6.4 billion for Q3 2025, which was down 799.62% from $6.6 billion recorded in Q2 2025.
  • Jazz Pharmaceuticals' 5-year Goodwill & Intangibles high stood at $9.5 billion for Q2 2021, and its period low was $3.0 billion during Q1 2021.
  • In the last 5 years, Jazz Pharmaceuticals' Goodwill & Intangibles had a median value of $7.2 billion in 2022 and averaged $7.2 billion.
  • Per our database at Business Quant, Jazz Pharmaceuticals' Goodwill & Intangibles skyrocketed by 19573.32% in 2021 and then tumbled by 2156.23% in 2022.
  • Quarter analysis of 5 years shows Jazz Pharmaceuticals' Goodwill & Intangibles stood at $9.0 billion in 2021, then fell by 16.62% to $7.5 billion in 2022, then fell by 4.22% to $7.2 billion in 2023, then fell by 9.75% to $6.5 billion in 2024, then fell by 1.22% to $6.4 billion in 2025.
  • Its Goodwill & Intangibles was $6.4 billion in Q3 2025, compared to $6.6 billion in Q2 2025 and $6.5 billion in Q1 2025.